UK announces establishment of AI biosecurity lab, backed by compute from OpenAI and Anthropic
The UK government announced the establishment of an AI biosecurity laboratory, which will receive £100 million in funding from the UK government, as well as support of up to a total of £200 million in technical resources such as compute from OpenAI and Anthropic. The laboratory will operate as an independent nonprofit institution, focusing on developing technologies to detect emerging biological threats early, and using AI to accelerate the R&D and testing of medical countermeasures such as vaccines and therapeutic drugs, while also conducting scientific research cooperation with Google DeepMind and UK biotechnology companies.
Why read this
AI score 58
The UK government is funding and, together with compute resources from OpenAI and Anthropic, establishing a laboratory, presenting a public-private cooperation path for AI biosecurity governance.
Topics
Body · AI translation
Add new crowd-testing promotional copy Add new crowd-testing promotional copy end Add App-exclusive traffic guidance
The UK government issued a communiqué that day saying that AI technology development is creating new opportunities for scientific discovery and disease research, but increasingly capable AI systems may also bring new biosafety risks and lower the technical threshold for carrying out harmful biological activities. To strengthen resilience against biological threats, the government decided to establish an AI biosafety laboratory.
The communiqué said the laboratory will receive 100 million pounds (about 134 million US dollars) in funding support from the UK government, as well as technical resource support including computing power totaling up to 200 million pounds (about 267 million US dollars) from two US AI companies, OpenAI and Anthropic. The laboratory will also carry out scientific research cooperation with Google DeepMind and UK biotechnology companies.
According to the introduction, the laboratory will bring together talent in the fields of AI and bioscience, focus on developing technologies that can detect emerging biological threats early, and use AI to accelerate the research, development and testing of vaccines, therapeutic drugs and other medical countermeasures, so as to improve the UK's ability to respond to disease outbreaks and future biological risks.
The UK government said the laboratory will operate as an independent non-profit institution and cooperate with government agencies such as the UK Health Security Agency and the Animal and Plant Health Agency. The laboratory will also cooperate with the UK Medicines and Healthcare products Regulatory Agency to carry out preparedness work for public health emergency response and provide reference for the regulation of AI-designed drugs. Statement: Exclusive article from Sina.com, unauthorized reproduction is prohibited. tech_web_article_v2015_block_bottom Non-targeted 300*250 button 17/09 wenjing begin
Non-targeted 300*250 button end